Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
29 studies found for:    PARKINSON DISEASE 12
Show Display Options
RSS Create an RSS feed from your search for:
PARKINSON DISEASE 12
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Condition: Idiopathic Parkinson's Disease
Interventions: Drug: Istradefylline 40 mg;   Drug: Istradefylline 20 mg;   Drug: Placebo
2 Completed Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (12 Month Extension)
Condition: Parkinson's Disease
Interventions: Drug: Safinamide;   Drug: Placebo
3 Completed 12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa
Condition: Parkinson's Disease
Intervention: Drug: Istradefylline (KW-6002)
4 Completed 12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa
Condition: Parkinson's Disease
Intervention: Drug: KW-6002 (istradefylline)
5 Completed
Has Results
A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period
Condition: Parkinson Disease
Interventions: Drug: Pramipexole Immediate Release;   Drug: Pramipexole Extended Release
6 Completed
Has Results
A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients
Condition: Parkinson Disease
Interventions: Drug: Pramipexole;   Drug: Placebo
7 Unknown  Vitamin B6, B12, Folic Acid and Exercise in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Dietary Supplement: PD vitamin supplementation;   Other: PD exercise intervention;   Other: PD vitamin + exercise
8 Terminated Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Dietary Supplement: Vitamin B12 Supplementation
9 Completed
Has Results
A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (P04938)
Condition: Parkinson Disease
Interventions: Drug: Preladenant 2 mg tablet;   Drug: Preladenant 5 mg tablet;   Drug: Preladenant 10 mg tablet;   Drug: Placebo to Preladenant Tablet;   Drug: Rasagiline 1 mg capsule;   Drug: Placebo to Rasagiline capsule
10 Completed Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: BF2.649 (pitolisant)
11 Completed Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: BF2.649 (Pitolisant)
12 Unknown  Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study
Condition: Parkinson's Disease
Intervention: Drug: Exenatide
13 Completed A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: AZD3241 300 mg BID;   Drug: AZD3241 600 mg BID;   Drug: Placebo
14 Recruiting Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes
Condition: Idiopathic Parkinson's Disease
Intervention: Drug: CVT-301
15 Completed A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
Condition: Parkinson's Disease
Intervention: Drug: Istradefylline (KW-6002)
16 Withdrawn Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off
Condition: Parkinson's Disease
Interventions: Drug: carbidopa/levodopa;   Drug: Carbidopa/Levodopa/Entacapone
17 Completed A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa
Condition: Parkinson's Disease
Intervention: Drug: Istradefylline (KW-6002)
18 Completed
Has Results
A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)
Condition: Parkinson's Disease
Interventions: Drug: Preladenant;   Drug: Placebo tablet to match Preladenant
19 Completed Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole
Condition: Parkinson Disease
Intervention: Drug: Ropinirole
20 Completed
Has Results
a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients
Condition: Parkinson Disease
Intervention: Drug: pramipexole

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.